IS7798A - Efnasambönd, lyfjablöndur og aðferðir - Google Patents

Efnasambönd, lyfjablöndur og aðferðir

Info

Publication number: IS7798A
Authority: IS; Iceland
Prior art keywords: compounds; methods; pharmaceutical preparations; preparations; pharmaceutical
Prior art date: 2002-10-11

Application number

IS7798A

Other languages

English (en)

Inventor

Bergnes Gustave

Qian Xianping

J. Morgans David Jr.

David Knight Steven

Dhanak Dashyant

Original Assignee

Cytokinetics, Incorporated

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2005-04-11

Publication date

2005-04-11

2005-04-11 Application filed by Cytokinetics, Incorporated, Smithkline Beecham Corporation filed Critical Cytokinetics, Incorporated

2005-04-11 Publication of IS7798A publication Critical patent/IS7798A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS7798A 2002-10-11 2005-04-11 Efnasambönd, lyfjablöndur og aðferðir IS7798A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US41788902P	2002-10-11	2002-10-11
PCT/US2003/031413 WO2004032840A2 (en)	2002-10-11	2003-10-02	Compounds, compositions, and methods

Publications (1)

Publication Number	Publication Date
IS7798A true IS7798A (is)	2005-04-11

Family

ID=32094113

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7798A IS7798A (is)	2002-10-11	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir

Country Status (19)

Country	Link
US (1)	US7476743B2 (is)
EP (1)	EP1558588A4 (is)
JP (1)	JP2006502219A (is)
KR (1)	KR20050075356A (is)
CN (1)	CN1726198A (is)
AR (1)	AR044193A1 (is)
AU (1)	AU2003282665A1 (is)
BR (1)	BR0315247A (is)
CA (1)	CA2501938A1 (is)
IL (1)	IL167936A0 (is)
IS (1)	IS7798A (is)
MX (1)	MXPA05003830A (is)
NO (1)	NO20052267L (is)
NZ (1)	NZ539643A (is)
PL (1)	PL375889A1 (is)
RU (1)	RU2005114491A (is)
TW (1)	TW200418818A (is)
WO (1)	WO2004032840A2 (is)
ZA (1)	ZA200503733B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006002236A1 (en) *	2004-06-18	2006-01-05	Novartis Vaccines And Diagnostics Inc.	N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
JP2008509977A (ja)	2004-08-18	2008-04-03	アストラゼネカアクチボラグ	癌の処置及び予防における選択された縮合複素環の鏡像異性体及びその使用
DE102006023337A1 (de) *	2006-05-18	2007-11-22	Merck Patent Gmbh	Triazolderivate II
JP5343363B2 (ja) *	2008-01-31	2013-11-13	アイシン精機株式会社	シートクッション調整装置
CN101643451B (zh) *	2008-08-07	2013-03-06	浙江海正药业股份有限公司	过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
KR20130100056A (ko)	2010-04-15	2013-09-09	노파르티스 아게	Ｋｓｐ 억제제로서의 트리아졸 화합물
WO2012095691A1 (en) *	2011-01-15	2012-07-19	Jubilant Life Sciences Ltd.	An improved process for producing aminopyridines
WO2013134562A1 (en)	2012-03-09	2013-09-12	Inception 2, Inc.	Triazolone compounds and uses thereof
JP6404230B2 (ja)	2012-12-20	2018-10-10	インセプション２、インコーポレイテッド	トリアゾロン化合物およびその使用
MX2016002795A (es)	2013-09-06	2016-05-26	Inception 2 Inc	Compuestos de triazolona y usos de los mismos.
EP4406606A3 (de)	2015-06-22	2024-10-09	Bayer Pharma Aktiengesellschaft	Binder-wirkstoff-konjugate (adcs) und binder-prodrug-konjugate (apdcs) mit enzymatisch spaltbaren g
TW201722958A (zh) *	2015-09-15	2017-07-01	葛蘭素史克智慧財產（第二）有限公司	化學化合物
JP7066714B2 (ja)	2016-12-21	2022-05-13	バイエル・ファルマ・アクティエンゲゼルシャフト	酵素的に切断可能な基を有する抗体薬物コンジュゲート（ａｄｃ）
US20250215039A1 (en) *	2022-03-30	2025-07-03	Primefour Therapeutics, Inc.	Nucleosides for treating cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE793532A (fr) *	1971-12-29	1973-06-29	Upjohn Co	Nouvelles 1,2,4-triazol-3-ones et leur preparation
US3748339A (en) *	1972-05-05	1973-07-24	Upjohn Co	2-(3-(1-(dimethylamino)alkyl)-1,5-dihydro-5-oxo - 1 - substituted-4h-1,2,4-triazol-4-yl)benzophenone and process
IT1068010B (it) *	1976-11-17	1985-03-21	Montedison Spa	Nuovi esteri fosforici derivati dall' 1-2-4 triazolo ad azione insetticida,nematocida e acaricida e loro preparazione
NL7712430A (nl)	1976-11-17	1978-05-19	Montedison Spa	Nieuwe fosforzuuresters, afgeleid van 1.2.4- -triazool, met een insecticide, nematocide en acaricide werking en werkwijze ter bereiding daarvan.
US4487773A (en) *	1981-03-16	1984-12-11	Mead Johnson & Company	1,2,4-Triazol-3-one antidepressants
US5250558A (en) *	1992-01-28	1993-10-05	Merck & Co., Inc.	Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
GB9211193D0 (en) *	1992-05-27	1992-07-08	Merck Sharp & Dohme	Therapeutic agents
CA2099233A1 (en) *	1992-06-29	1993-12-30	Conrad P. Dorn	Morpholine and thiomorpholine tachykinin receptor antagonists
WO1997014671A1 (en) *	1995-10-18	1997-04-24	Merck & Co., Inc.	Cyclopentyl tachykinin receptor antagonists
JP2002234874A (ja) *	2000-09-26	2002-08-23	Tanabe Seiyaku Co Ltd	５−フェニルベンジルアミン誘導体、その製法及びその合成中間体
CA2425908A1 (en) *	2000-10-26	2002-05-02	Merck & Co., Inc.	Mammalian metabolites of a tachykinin receptor antagonist
WO2003105855A1 (en) *	2002-01-11	2003-12-24	Merck & Co., Inc.	Mitotic kinesin inhibitors

2003
- 2003-10-02 CN CNA200380105737XA patent/CN1726198A/zh active Pending
- 2003-10-02 KR KR1020057006260A patent/KR20050075356A/ko not_active Withdrawn
- 2003-10-02 PL PL03375889A patent/PL375889A1/xx unknown
- 2003-10-02 BR BR0315247-2A patent/BR0315247A/pt not_active IP Right Cessation
- 2003-10-02 MX MXPA05003830A patent/MXPA05003830A/es unknown
- 2003-10-02 AU AU2003282665A patent/AU2003282665A1/en not_active Abandoned
- 2003-10-02 RU RU2005114491/04A patent/RU2005114491A/ru not_active Application Discontinuation
- 2003-10-02 US US10/529,634 patent/US7476743B2/en not_active Expired - Fee Related
- 2003-10-02 WO PCT/US2003/031413 patent/WO2004032840A2/en not_active Ceased
- 2003-10-02 CA CA002501938A patent/CA2501938A1/en not_active Abandoned
- 2003-10-02 EP EP03774548A patent/EP1558588A4/en not_active Withdrawn
- 2003-10-02 NZ NZ539643A patent/NZ539643A/en unknown
- 2003-10-02 JP JP2004543136A patent/JP2006502219A/ja active Pending
- 2003-10-09 TW TW092128029A patent/TW200418818A/zh unknown
- 2003-10-09 AR ARP030103684A patent/AR044193A1/es unknown
2005
- 2005-04-10 IL IL167936A patent/IL167936A0/en unknown
- 2005-04-11 IS IS7798A patent/IS7798A/is unknown
- 2005-05-10 NO NO20052267A patent/NO20052267L/no not_active Application Discontinuation
- 2005-05-10 ZA ZA200503733A patent/ZA200503733B/en unknown

Also Published As

Publication number	Publication date
MXPA05003830A (es)	2005-06-23
AU2003282665A1 (en)	2004-05-04
TW200418818A (en)	2004-10-01
CN1726198A (zh)	2006-01-25
ZA200503733B (en)	2006-02-22
IL167936A0 (en)	2009-02-11
KR20050075356A (ko)	2005-07-20
NO20052267L (no)	2005-05-31
EP1558588A4 (en)	2006-11-02
US20060189671A1 (en)	2006-08-24
AR044193A1 (es)	2005-09-07
NZ539643A (en)	2006-11-30
EP1558588A2 (en)	2005-08-03
CA2501938A1 (en)	2004-04-22
WO2004032840A2 (en)	2004-04-22
RU2005114491A (ru)	2006-02-10
PL375889A1 (en)	2005-12-12
JP2006502219A (ja)	2006-01-19
BR0315247A (pt)	2005-08-30
WO2004032840A3 (en)	2004-10-14
US7476743B2 (en)	2009-01-13

Publication	Publication Date	Title
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
KR20050009999A (ko)	2005-01-26	약제학적 제제
NO20052855D0 (no)	2005-06-13	Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
NO20053817D0 (no)	2005-08-12	Preparater og fremgangsmater for antiviral kombinasjonsterapi.
NO20044192L (no)	2004-10-04	17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033556D0 (no)	2003-08-11	Farmasöytiske preparater
IS8153A (is)	2005-11-28	Ónæmisbælandi efnasambönd og efnablöndur
NO20042084L (no)	2004-05-21	6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
DK1400518T3 (da)	2007-03-26	Heterocycliske forbindelser og lægemidler
NO20043839L (no)	2004-11-12	Havbunnsbasert intervensjonssystem, fremgangsmate for og komponeter i dette
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
DK1575618T3 (da)	2006-11-13	Dispergerbare farmaceutiske kombinationer
IS7549A (is)	2004-11-24	Olíuleysanlegar efnablöndur
FI20021184L (fi)	2003-12-20	Lignaanivalmisteita
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
NO20035315D0 (no)	2003-11-28	Farmasöytiske kombinasjoner
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1560826T3 (da)	2006-08-14	Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
IS8219A (is)	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
NO20054674L (no)	2005-12-13	Benzotiazolderivatforbindelser, preperater og anvendelser
DE60328119D1 (de)	2009-08-06	Pharmazeutische zubereitungen enthaltend modafinil
NO20053809D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav